Cargando…
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
Reduced COVID‐19 vaccine effectiveness (VE) has been observed with increasing predominance of SARS‐CoV‐2 Delta (B.1.617.2) variant. Two‐dose VE against laboratory‐confirmed SARS‐CoV‐2 infection (symptomatic and asymptomatic) was estimated using Cox proportional hazards models with time‐varying vacci...
Autores principales: | McLean, Huong Q., McClure, David L., King, Jennifer P., Meece, Jennifer K., Pattinson, David, Neumann, Gabriele, Kawaoka, Yoshihiro, Rolfes, Melissa A., Belongia, Edward A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111813/ https://www.ncbi.nlm.nih.gov/pubmed/35178857 http://dx.doi.org/10.1111/irv.12970 |
Ejemplares similares
-
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
por: Petrie, Joshua G., et al.
Publicado: (2023) -
Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023
por: McLean, Huong Q., et al.
Publicado: (2023) -
446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort
por: Sundaram, Maria, et al.
Publicado: (2023) -
Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection — Tennessee and Wisconsin, April–September 2020
por: Rolfes, Melissa A., et al.
Publicado: (2021) -
Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020
por: Grijalva, Carlos G., et al.
Publicado: (2020)